Terms: = Cervical cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Clinical Outcome
276 results:
1. Impact of histological subtypes on clinical outcome of endocervical adenocarcinoma.
Tian X; Liu P; Kang S; Cui Z; Sun L; Lang J; Chen C
Eur J Surg Oncol; 2024 Apr; 50(4):107977. PubMed ID: 38373385
[TBL] [Abstract] [Full Text] [Related]
2. Survival and neurological outcomes following management of intramedullary spinal metastasis patients: a case series with comprehensive review of the literature.
Kritikos M; Vivanco-Suarez J; Teferi N; Lee S; Kato K; Eschbacher KL; Bathla G; Buatti JM; Hitchon PW
Neurosurg Rev; 2024 Feb; 47(1):75. PubMed ID: 38319484
[TBL] [Abstract] [Full Text] [Related]
3. Role of Lymphovascular Invasion in Oral Cavity Squamous Cell Carcinoma Regional Metastasis and Prognosis.
Moore AE; Alvi SA; Tarabichi O; Zhu VL; Buchakjian MR
Ann Otol Rhinol Laryngol; 2024 Mar; 133(3):300-306. PubMed ID: 37927046
[TBL] [Abstract] [Full Text] [Related]
4. Automated localization and segmentation of cervical lymph nodes on contrast-enhanced CT using a 3D foveal fully convolutional neural network.
Rinneburger M; Carolus H; Iuga AI; Weisthoff M; Lennartz S; Hokamp NG; Caldeira L; Shahzad R; Maintz D; Laqua FC; Baeßler B; Klinder T; Persigehl T
Eur Radiol Exp; 2023 Jul; 7(1):45. PubMed ID: 37505296
[TBL] [Abstract] [Full Text] [Related]
5. The mRNA and protein levels of the glycolytic enzymes lactate dehydrogenase A (LDHA) and phosphofructokinase platelet (PFKP) are good predictors of survival time, recurrence, and risk of death in cervical cancer patients.
Bolaños-Suárez V; Alfaro A; Espinosa AM; Medina-Martínez I; Juárez E; Villegas-Sepúlveda N; Gudiño-Zayas M; Gutiérrez-Castro A; Román-Bassaure E; Salinas-Nieves ME; Bruno-Muñoz S; Aranda C; Flores-Herrera O; Berumen J
Cancer Med; 2023 Jul; 12(14):15632-15649. PubMed ID: 37326348
[TBL] [Abstract] [Full Text] [Related]
6. Thrombogenesis-associated genetic determinants as predictors of thromboembolism and prognosis in cervical cancer.
Neto BV; Tavares V; da Silva JB; Liz-Pimenta J; Marques IS; Carvalho L; Salgado L; Pereira D; Medeiros R
Sci Rep; 2023 Jun; 13(1):9519. PubMed ID: 37308506
[TBL] [Abstract] [Full Text] [Related]
7. The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
Song S; Han D; Zhang N; Mao Z; Guo X; Cheng G
Radiat Oncol; 2023 Mar; 18(1):46. PubMed ID: 36879287
[TBL] [Abstract] [Full Text] [Related]
8. Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic.
Chopra S; Mulani J; Mittal P; Singh M; Shinde A; Gurram L; Scaria L; Aravindakshan D; Kohle S; Rane P; Ghadi Y; Rath S; Ghosh J; Gulia S; Gupta S; Kinhikar R; Laskar S; Agarwal JP
Brachytherapy; 2023; 22(2):125-131. PubMed ID: 36585283
[TBL] [Abstract] [Full Text] [Related]
9. Diffusion basis spectrum imaging predicts long-term clinical outcomes following surgery in cervical spondylotic myelopathy.
Zhang JK; Jayasekera D; Javeed S; Greenberg JK; Blum J; Dibble CF; Sun P; Song SK; Ray WZ
Spine J; 2023 Apr; 23(4):504-512. PubMed ID: 36509379
[TBL] [Abstract] [Full Text] [Related]
10. Positive
Huang S; Qi M; Tian T; Dai H; Tang Y; Huang R
Front Endocrinol (Lausanne); 2022; 13():959089. PubMed ID: 36407316
[TBL] [Abstract] [Full Text] [Related]
11. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: clinical outcome and prognostic factors.
Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
[TBL] [Abstract] [Full Text] [Related]
12. The Relevance of High Temperatures and Short Time Intervals Between Radiation Therapy and Hyperthermia: Insights in Terms of Predicted Equivalent Enhanced Radiation Dose.
Kok HP; Herrera TD; Crezee J
Int J Radiat Oncol Biol Phys; 2023 Mar; 115(4):994-1003. PubMed ID: 36288756
[TBL] [Abstract] [Full Text] [Related]
13. The long-term outcomes of clinical responders to neoadjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer.
Li W; Liu P; He F; Sun L; Zhao H; Wang L; Guo J; Yang Y; Bin X; Lang J; Chen C
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4867-4876. PubMed ID: 36269389
[TBL] [Abstract] [Full Text] [Related]
14. Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting.
Sherif S; Mall R; Almeer H; Naik A; Al Homaid A; Thomas R; Roelands J; Narayanan S; Mohamed MG; Bedri S; Al-Bader SB; Junejo K; Bedognetti D; Hendrickx W; Decock J
J Transl Med; 2022 Sep; 20(1):442. PubMed ID: 36180904
[TBL] [Abstract] [Full Text] [Related]
15. Epidemiology and Molecular Biology of HPV Variants in cervical cancer: The State of the Art in Mexico.
Muñoz-Bello JO; Carrillo-García A; Lizano M
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955700
[TBL] [Abstract] [Full Text] [Related]
16. Influence of Grading on Management and outcome in Mucoepidermoid Carcinoma of the Parotid-A Multi-institutional Analysis.
Grasl S; Janik S; Faisal M; Grasl MC; Pammer J; Weinreb I; Fischer G; Kim J; Hosni A; de Almeida JR; Goldstein DP; Erovic BM
Laryngoscope; 2023 Jan; 133(1):124-132. PubMed ID: 35475580
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcome of pulmonary lymphangitic carcinomatosis in gynecologic malignancy: A single-institution experience.
Kim MS; Jeong SY; Lee YY; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Taiwan J Obstet Gynecol; 2022 Mar; 61(2):333-338. PubMed ID: 35361397
[TBL] [Abstract] [Full Text] [Related]
18. Radiomics-based prediction of two-year clinical outcome in locally advanced cervical cancer patients undergoing neoadjuvant chemoradiotherapy.
Autorino R; Gui B; Panza G; Boldrini L; Cusumano D; Russo L; Nardangeli A; Persiani S; Campitelli M; Ferrandina G; Macchia G; Valentini V; Gambacorta MA; Manfredi R
Radiol Med; 2022 May; 127(5):498-506. PubMed ID: 35325372
[TBL] [Abstract] [Full Text] [Related]
19. clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy.
Zeng J; Sun P; Ping Q; Jiang S; Hu Y
PLoS One; 2022; 17(3):e0266001. PubMed ID: 35324998
[TBL] [Abstract] [Full Text] [Related]
20. Effects of steroid use for stenosis prevention after endoscopic submucosal dissection for cervical esophageal cancer.
Muroi K; Kakushima N; Furukawa K; Furune S; Ito N; Hirose T; Ishikawa E; Mizutani Y; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Funasaka K; Miyahara R; Fujishiro M
Int J Clin Oncol; 2022 May; 27(5):940-947. PubMed ID: 35194703
[TBL] [Abstract] [Full Text] [Related]
[Next]
